- Home
- VALU vs FBRX Comparison
VALU vs FBRX Comparison
Compare VALU & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALU | FBRX |
|---|---|---|
| Founded | 1931 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.4M | 367.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VALU | FBRX |
|---|---|---|
| Price | $37.76 | $22.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 3.5K | ★ 171.4K |
| Earning Date | 12-15-2025 | 11-14-2025 |
| Dividend Yield | ★ 3.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.26 | N/A |
| Revenue | ★ $34,516,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.49 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.94 | $4.90 |
| 52 Week High | $54.30 | $31.27 |
Technical Indicators
Market Signals| Indicator | VALU | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 48.44 |
| Support Level | $37.19 | $24.79 |
| Resistance Level | $39.03 | $27.65 |
| Average True Range (ATR) | 1.00 | 3.25 |
| MACD | -0.11 | -0.61 |
| Stochastic Oscillator | 35.23 | 22.13 |
Price Performance
Historical ComparisonAbout VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).